Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients

相似书籍

• “Hemolysis, or not Hemolysis, that is the question”. Use of hydroxychloroquine in a patient with COVID-19 infection and G6PD deficiency.
  由: NICOLA SGHERZA, et al.
  出版: (2020-10-01)
• Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study
  由: Nicola Sgherza, et al.
  出版: (2021-11-01)
• Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
  由: NICOLA SGHERZA, et al.
  出版: (2023-01-01)
• Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study
  由: Francesco Paolo Bianchi, et al.
  出版: (2022-03-01)
• SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
  由: Nicola Sgherza, et al.
  出版: (2022-12-01)